Wa Univ Sch Med Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WA UNIV SCH MED
WA UNIV SCH MED has two approved drugs.
Drugs and US Patents for Wa Univ Sch Med
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wa Univ Sch Med | CHOLINE C-11 | choline c-11 | INJECTABLE;INTRAVENOUS | 208413-001 | Jan 10, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Wa Univ Sch Med | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 204506-002 | Feb 13, 2026 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Wa Univ Sch Med | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 204506-001 | Feb 7, 2014 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

